The importance of intravascular coagulation and inhibition of the fibrinolytic system in experimental fat embolism.
D000273:Adipose Tissue; D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001778:Blood Coagulation Disorders; D001921:Brain / Q000187:drug effects / Q000473:pathology; D004620:Embolism, Fat / Q000401:mortality; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006470:Hemorrhage; D006493:Heparin / Q000494:pharmacology; D007275:Injections, Intravenous; D002542:Intracranial Embolism and Thrombosis; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008168:Lung / Q000187:drug effects / Q000473:pathology; D011651:Pulmonary Artery; D011655:Pulmonary Embolism; D011667:Pulmonary Veins; D011851:Radioactivity; D011868:Radioisotopes; D051381:Rats; D013925:Thromboplastin
D000614:Aminocaproates; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D011868:Radioisotopes; D006493:Heparin; D013925:Thromboplastin